Transgenic mice expressing the mutations of familial-associated AD genes (APP/PS1/PS2) progressively developed brain Aβ plaques and memory deficits, reinforcing the relation between amyloid deposition and memory impairment [31]. The gene discussed is APP; the disease is amyloidosis.